Adeoye Y Olukotun Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Adeoye Y Olukotun is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 35,781 shares of ARWR, which is worth approximately $723,849. The most recent transaction as insider was on Jan 23, 2025, when has been sold 959 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $20,139. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.8K

56.56% 3M change

56.56% 12M change

Total Value Held $723,849

ADEOYE Y OLUKOTUN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2025	SELL Open market or private sale	$20,139 $21.0 p/Share	959 Reduced 2.61%	35,781 Common Stock
Dec 27 2024	SELL Open market or private sale	$57,000 $20.0 p/Share	2,850 Reduced 7.2%	36,740 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	$384,691 $22.99 p/Share	16,733 Added 29.71%	39,590 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	$380,819 $25.41 p/Share	14,987 Added 39.61%	22,854 Common Stock
Mar 03 2023	SELL Open market or private sale	$370,577 $32.65 p/Share	11,350 Reduced 59.06%	7,867 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 29.05%	19,217 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 36.06%	11,350 Common Stock
Jan 03 2022	SELL Open market or private sale	$263,979 $65.18 p/Share	4,050 Reduced 45.0%	4,950 Common Stock
Sep 13 2021	SELL Open market or private sale	$318,800 $63.76 p/Share	5,000 Reduced 35.71%	9,000 Common Stock
Jan 01 2021	BUY Grant, award, or other acquisition	-	9,000 Added 39.13%	14,000 Common Stock

Also insider at

TNXP

Tonix Pharmaceuticals Holding Corp. Healthcare

Director

AYO